# ELEVANCE HEALTH, INC. (ELV) FY2024 Annual P&L / Income Statement

- Company: ELEVANCE HEALTH, INC. (ELV)
- Period: 2024-01-01 to 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-20, accession number 0001156039-25-000010
- Page: https://plicit.ai/financials/elv/fy2024-annual-income-statement
- Chart image: https://plicit.ai/charts/elv-fy2024-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service (4 categories)

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 177,011,000,000 US dollars
- **Total expenses**: 169,107,000,000 US dollars
- **Operating profit (calculated)**: 7,904,000,000 US dollars
- **Other income (expense), net (calculated)**: 0 US dollars
- **Income before income tax expense**: 7,904,000,000 US dollars
- **Income tax expense**: 1,933,000,000 US dollars
- **Net income**: 5,971,000,000 US dollars
- **Net investment income**: 2,051,000,000 US dollars
- **Total operating revenue**: 175,204,000,000 US dollars
- **Gain on sale of business**: 201,000,000 US dollars
- **Benefit expense**: 127,567,000,000 US dollars
- **Cost of products sold**: 19,750,000,000 US dollars
- **Operating expense**: 20,025,000,000 US dollars
- **Interest expense**: 1,185,000,000 US dollars
- **Amortization of other intangible assets**: 580,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 177,456,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Net losses on financial instruments**: negative 445,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to ELEVANCE HEALTH, INC.: $5.98 B; to noncontrolling interests: −$9.00 M.